15.09.2017 15:25:54

Biomarin Pharmaceutical Sector Perform

Der Analyst RBC Capital Markets hat die Einstufung für Biomarin Pharmaceutical Inc. auf "Sector Perform" mit einem Kursziel von 93 USD belassen.
Zusammenfassung: Biomarin Pharmaceutical Inc. Sector Perform
Unternehmen:
Biomarin Pharmaceutical Inc.
Analyst:
RBC Capital Markets
Kursziel:
$ 93.00
Rating jetzt:
Sector Perform
Kurs*:
$ 91.23
Abst. Kursziel*:
1.94%
Rating update:
initiated
Kurs aktuell:
$ 99.03
Abst. Kursziel aktuell:
-6.09%
Analyst Name::
-
KGV*:
-
* Zum Zeitpunkt der Analyse

Analysen zu Biomarin Pharmaceutical Inc.mehr Analysen

16.05.18 Biomarin Pharmaceutical Buy Canaccord Adams
15.09.17 Biomarin Pharmaceutical Sector Perform RBC Capital Markets
14.07.17 Biomarin Pharmaceutical Outperform BMO Capital Markets
30.03.17 Biomarin Pharmaceutical Neutral UBS AG
02.03.17 Biomarin Pharmaceutical Neutral Instinet

Eintrag hinzufügen

Aktien in diesem Artikel

Aktuelle Aktienanalysen

08:52 Credit Suisse Group
SAP Outperform
08:42 equinet AG
Daimler buy
08:39 Baader Bank
Evonik buy
08:39 Barclays Capital
Roche overweight
08:27 Baader Bank
Roche buy
08:26 Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
Deutsche Wohnen buy
08:15 Barclays Capital
Novartis Underweight
08:06 Credit Suisse Group
Nokia Neutral
08:04 Credit Suisse Group
Wirecard Neutral
07:40 Bernstein Research
Novo Nordisk market-perform
07:38 Barclays Capital
1&1 Drillisch overweight
07:36 JP Morgan Chase & Co.
PUMA overweight
06:47 Goldman Sachs Group Inc.
Südzucker Sell
22.06.18 Bernstein Research
Tesla market-perform
22.06.18 Barclays Capital
Webcom Group Equal weight
22.06.18 Barclays Capital
Red Hat overweight
22.06.18 BMO Capital Markets
Scholar Rock Outperform
22.06.18 Barrington Research
Chegg Outperform
22.06.18 Seaport Global Securities
BioCryst Pharmaceuticals Neutral
22.06.18 Wedbush Morgan Securities Inc.
TJX Cos Neutral
22.06.18 Wedbush Morgan Securities Inc.
Ross Stores Neutral
22.06.18 Wedbush Morgan Securities Inc.
Burlington Stores Outperform
22.06.18 Oppenheimer & Co. Inc.
Altery a Outperform
22.06.18 DZ BANK
ASML NV Verkaufen
22.06.18 Macquarie Research
Amazon Outperform
22.06.18 Goldman Sachs Group Inc.
Danone Neutral
22.06.18 Needham & Company, LLC
Electronic Arts Buy
22.06.18 Monness, Crespi, Hardt & Co.
Red Hat Buy
22.06.18 RBC Capital Markets
ING Group Outperform
22.06.18 RBC Capital Markets
Prudential Sector Perform
22.06.18 Deutsche Bank AG
Engie SA Hold
22.06.18 Deutsche Bank AG
Iberdrola SA buy
22.06.18 Maxim Group
The Cheesecake Factory Hold
22.06.18 The Benchmark Company
Booking Hold
22.06.18 The Benchmark Company
Micron Technology Buy
22.06.18 Needham & Company, LLC
KLA-Tencor Hold
22.06.18 Needham & Company, LLC
G-III Apparel Group Buy
22.06.18 Needham & Company, LLC
DS a Buy
22.06.18 Needham & Company, LLC
Brown Shoe Company Hold
22.06.18 B. Riley FBR, Inc.
WideOpenWest Buy
22.06.18 B. Riley FBR, Inc.
Cable One Buy
22.06.18 B. Riley FBR, Inc.
Amneal Pharmaceutical a Buy
22.06.18 Warburg Research
Hornbach buy
22.06.18 Hauck & Aufhäuser Privatbankiers KGaA
JENOPTIK buy
22.06.18 Hauck & Aufhäuser Privatbankiers KGaA
LEONI buy
22.06.18 Goldman Sachs Group Inc.
ABB Conviction Buy List
22.06.18 Goldman Sachs Group Inc.
Schneider Electric Neutral
22.06.18 Goldman Sachs Group Inc.
Takeawaycom buy
22.06.18 Goldman Sachs Group Inc.
Delivery Hero buy
22.06.18 UBS AG
Siemens buy